证券代码：300795 证券简称：米奥会展 公告编号：2025-081 浙江米奥兰特商务会展股份有限公司 关于召开2025年第三次临时股东会的提示性公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整， 没有虚假记载、误导性陈述或重大遗漏。 浙江米奥兰特商务会展股份有限公司（以下简称"公司"）于 2025 年 11 月 25 日在中国证监会指定创业板信息披露网站巨潮资讯网 （www.cninfo.com.cn）披露了《关于召开公司 2025 年第三次临时股 东会通知的公告》（公告编号：2025-079），本次股东会将采取现场投 票与网络投票相结合的方式召开，根据相关规定，现将本次会议的有 关情况提示如下： （1）现场会议时间：2025 年 12 月 12 日 14:45 第 1 页 共 10 页 （2）网络投票时间：通过深圳证券交易所系统进行网络投票的 具体时间为2025年12月12日9:15-9:25，9:30-11:30，13:00-15:00； 通过深圳证券交易所互联网投票系统投票的具体时间为2025年12月 12 日 9:15 至 15:00 的任意时间。 一、召开会议的基本情况 1、股东会 ...

Group 1 - The core viewpoint of the news is that Miao Exhibition has shown a positive stock performance recently, with a 2.06% increase in stock price on December 2, reaching 15.88 CNY per share, and a total market capitalization of 4.746 billion CNY [1] - The company has experienced a net inflow of main funds amounting to 6.5477 million CNY, with significant buying activity from large orders [1] - Miao Exhibition's stock price has increased by 5.07% year-to-date, with a notable rise of 7.88% over the last five trading days and 11.60% over the last twenty days [1] Group 2 - As of September 30, the number of shareholders for Miao Exhibition is 12,000, reflecting a decrease of 6.98% from the previous period, while the average circulating shares per person increased by 7.36% to 14,435 shares [2] - For the period from January to September 2025, Miao Exhibition reported a revenue of 401 million CNY, a year-on-year decrease of 5.67%, and a net profit attributable to shareholders of 34.6337 million CNY, down 49.17% year-on-year [2] - The company has distributed a total of 344 million CNY in dividends since its A-share listing, with 244 million CNY distributed over the past three years [3]

Core Viewpoint - Miao Exhibition's stock price has shown a positive trend recently, with a 2.24% increase on December 1, 2023, and a total market capitalization of 4.642 billion yuan [1] Group 1: Stock Performance - As of December 1, 2023, Miao Exhibition's stock price is 15.53 yuan per share, with a trading volume of 75.52 million yuan and a turnover rate of 2.85% [1] - Year-to-date, the stock price has increased by 2.75%, with a 4.51% rise over the last five trading days and a 9.75% increase over the last 20 days, while it has decreased by 2.47% over the last 60 days [1] Group 2: Financial Performance - For the period from January to September 2025, Miao Exhibition reported a revenue of 401 million yuan, a year-on-year decrease of 5.67%, and a net profit attributable to shareholders of 34.63 million yuan, down 49.17% year-on-year [1] - The company has distributed a total of 344 million yuan in dividends since its A-share listing, with 244 million yuan distributed over the past three years [2] Group 3: Shareholder Information - As of September 30, 2025, Miao Exhibition had 12,000 shareholders, a decrease of 6.98% from the previous period, with an average of 14,435 circulating shares per shareholder, an increase of 7.36% [1] - Among the top ten circulating shareholders, the Jiashi Theme New Power Mixed Fund (070021) holds 1.3794 million shares, having decreased its holdings by 189,200 shares compared to the previous period [2]

Core Viewpoint - The trend of A-share companies planning to list in Hong Kong continues, with 18 companies disclosing their intentions to issue H-shares and list on the Hong Kong Stock Exchange in November [1] Group 1: Companies Planning to List - 18 A-share listed companies have announced plans to issue H-shares and list in Hong Kong from November 1 to November 29 [1] - Zhongji Xuchuang announced on November 10 its intention to issue H-shares and list on the Hong Kong Stock Exchange [1] Group 2: Specific Company Announcements - Runjian Co., Ltd. announced on November 25 its plan to issue H-shares and list in Hong Kong [2] - Ningbo Yunsheng authorized management on November 24 to initiate preparations for issuing H-shares and listing in Hong Kong [2] - Igor announced on November 24 its plan to issue H-shares and list in Hong Kong [2] - Miao Exhibition announced on November 24 its intention to issue H-shares and list in Hong Kong [2] - Zhuoyi Information announced on November 20 its plan to issue H-shares and list in Hong Kong [2] - Yuanjie Technology announced on November 19 its intention to issue H-shares and list in Hong Kong [2] - Dashang Co., Ltd. announced on November 18 its plan to issue H-shares and list in Hong Kong [2] - Sifang Jingchuang announced on November 14 its intention to issue H-shares and list on the main board of the Hong Kong Stock Exchange [2] - Zejing Pharmaceutical announced on November 14 its plan to issue H-shares and list in Hong Kong [2] - Juxin Technology announced on November 14 its intention to issue H-shares and list in Hong Kong [2] - Deye Co., Ltd. announced on November 13 its plan to issue H-shares and list in Hong Kong [2] - Tuosida announced on November 12 its intention to issue H-shares and list in Hong Kong [2] - Marumi Bio announced on November 12 its plan to issue H-shares and apply for listing in Hong Kong [2] - Transsion Holdings announced on November 12 its intention to issue H-shares and list in Hong Kong [2] - Anker Innovations announced on November 11 its plan to issue H-shares and list in Hong Kong [2] - Visual China announced on November 4 that it is planning to issue H-shares [2] - Juhe Materials announced on November 3 its plan to issue FF shares and list in Hong Kong [2]

浙江米奥兰特商务会展股份有限公司 关于对外投资设立控股子公司的进展公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整， 没有虚假记载、误导性陈述或重大遗漏。 一、对外投资概述 浙江米奥兰特商务会展股份有限公司（以下简称"公司"）为了 顺应中国企业品牌出海及国际贸易订单碎片化的趋势，通过资源整合 与优势互补，增强协同效应，促进公司的可持续发展，于 2025 年 10 月 20 日召开第六届董事会第三次会议，审议通过了《关于对外投资 设立控股子公司的议案》，同意公司以自有资金与 Panex WD International Limited 共同投资设立合资公司，公司拟以货币出资 人民币 5,100 万元，认缴比例为 51%，合资公司设立后将成为公司控 股子公司并纳入公司合并报表范围内，该控股子公司的注册资本为人 民币 10,000 万元。 具体内容详见公司刊登在中国证监会指定的创业板信息披露网 站巨潮资讯网（www.cninfo.com.cn）上披露的《关于对外投资设立 控股子公司的公告》（公告编号：2025-066）。 二、对外投资进展情况 目前，公司控股子公司已完成工商注册登记手续，取得了慈溪市 ...

Group 1 - The core viewpoint of the news is that Miao Exhibition has seen a significant increase in its stock price, rising by 5.77% to reach 15.77 yuan per share, with a total market capitalization of 4.714 billion yuan [1] - Miao Exhibition, established on June 30, 2010, and listed on October 22, 2019, specializes in planning, organizing, promoting, and operating exhibition projects, with 100% of its revenue coming from self-organized exhibitions [1] - The trading volume for Miao Exhibition reached approximately 70.5 million yuan, with a turnover rate of 2.72% [1] Group 2 - From the perspective of major shareholders, the fund managed by Jiashi Fund holds a position among the top ten circulating shareholders of Miao Exhibition, having reduced its holdings by 189,200 shares in the third quarter, now holding 1.3794 million shares, which is 0.8% of the circulating shares [2] - Jiashi Theme New Power Mixed Fund (070021) has achieved a year-to-date return of 21.63%, ranking 3608 out of 8130 in its category, and a one-year return of 14.2%, ranking 5068 out of 8054 [2] - Jiashi Multi-Dimensional Power Mixed A Fund (014307) has also reduced its holdings in Miao Exhibition by 13,300 shares, now holding 208,400 shares, which constitutes 3.68% of the fund's net value [4] Group 3 - The fund manager for Jiashi Theme New Power Mixed Fund is Meng Xia, who has been in the position for 5 years and 130 days, with the fund's total asset size at 6.83 billion yuan [3] - Meng Xia's best fund return during his tenure is 65.24%, while the worst return is -1.51% [3][5] - Jiashi Multi-Dimensional Power Mixed A Fund, also managed by Meng Xia, has a total asset size of 6.83 billion yuan, with a year-to-date return of 28.14% [4][5]

分组1 - Weili Medical plans to distribute a cash dividend of 2 yuan per 10 shares to all shareholders, based on an undistributed profit of 704 million yuan as of September 30, 2025 [1] - Tongding Interconnect's shareholder plans to reduce their stake by up to 0.49%, equating to a maximum of 605,800 shares [1] - Caitong Securities has received approval from the China Securities Regulatory Commission to issue short-term corporate bonds with a total face value of up to 5 billion yuan [1] 分组2 - Youfu Food intends to use 70 million yuan of its own funds to invest in wealth management products with expected annual returns of up to 4.2% [3] - Keres received an administrative regulatory decision from the Guangdong Securities Regulatory Bureau for violations related to accounts receivable aging calculations and related party transactions [5] - Ouma Software's controlling shareholder has completed the transfer of state-owned equity, changing the controlling shareholder to Shandong Guotou [7] 分组3 - ST Huapeng's wholly-owned subsidiary has completed a major overhaul project and is now in production [8] - Beiqi Blue Valley has received approval from the China Securities Regulatory Commission for a stock issuance to specific investors [8] - Weijie Chuangxin received a government subsidy of 5 million yuan, accounting for 21.07% of its projected net profit for 2024 [9] 分组4 - China Resources Double Crane's subsidiary has received a drug registration certificate for a hypertension treatment drug [11] - Huafeng shares are continuing to suspend trading due to a planned change in control [13] - Kaifa Electric's shareholder plans to transfer 36.6869 million shares, representing 11.63% of the total share capital [14] 分组5 - Heng Rui Medicine has received approval for two clinical trials for innovative anti-tumor drugs [15] - Kosen Technology plans to invest 30 million USD to establish a new production base in Malaysia [17] - Sanxing Medical's subsidiary is expected to win a procurement project from the State Grid worth approximately 107 million yuan [18] 分组6 - Sitai Li's subsidiary has received a drug registration certificate for a contrast agent used in MRI [21] - Daren Tang's subsidiary has received a drug registration certificate for a pain relief gel [22] - Saike Xide has received approval for three medical device products, expanding its product range in the in vitro diagnostic field [23] 分组7 - Hasa Lian has elected a new chairman and vice chairman for its board of directors [24] - Two-sided Needle's subsidiary plans to invest 68.8522 million yuan in a production base expansion project [25] - Sunshine Nuohe plans to transfer 70% of its controlling subsidiary's equity for 2 million yuan [26] 分组8 - Hengbang shares received an administrative regulatory decision from the Shandong Securities Regulatory Bureau for failing to complete the election of independent directors [27] - Huali shares plan to sign a related transaction contract worth approximately 59.2847 million yuan [28] - Shangwei shares plan to invest 520.4 million yuan to gain a controlling stake in Sichuan Zhongfu Taihua [30] 分组9 - Zejing Pharmaceutical's ZG006 has been included in the list of breakthrough therapeutic varieties for treating advanced neuroendocrine cancer [32] - Yaopi Glass's shareholder plans to reduce their stake by up to 2.26%, equating to a maximum of 21.1469 million shares [34] - Huate Gas has initiated a major lawsuit involving a claim of 180 million yuan [36] 分组10 - Zhongchumei's controlling shareholder plans to increase their stake by between 42 million and 80 million yuan [37] - Huitong shares' shareholder plans to reduce their stake by up to 1% [38] - Miaowei Exhibition plans to apply for an initial public offering of H shares on the Hong Kong Stock Exchange [40] 分组11 - Tianqi Lithium's subsidiary has appealed to the Chilean Supreme Court regarding a partnership agreement with SQM and Codelco [42] - Naxin Micro plans to repurchase shares worth between 200 million and 400 million yuan [44] - Pingao shares have reported significant uncertainty regarding future business development and profitability [46] 分组12 - Shunyu shares have been pre-selected for a project worth 1.023 billion yuan [48] - Zhongyuan Neipei plans to acquire a 2.5% share in an aerospace industry fund for 50 million yuan [50] - Huifa Food's shareholder plans to reduce their stake by up to 3%, equating to a maximum of 727.14 million shares [53] 分组13 - Junshi Biosciences' subcutaneous PD-1 new formulation has reached its primary endpoint in a Phase III clinical trial [54] - Industrial Fulian clarified that it has not lowered its fourth-quarter profit target amid market rumors [55] - Longpan Technology's subsidiary has signed a major supply agreement for lithium iron phosphate materials, significantly increasing the supply volume [56]

Group 1 - The company Miao Exhibition announced the convening of its sixth fifth board meeting on November 24, 2025, via video conference to review the proposal for issuing H-shares and listing on the Hong Kong Stock Exchange [1] - For the first half of 2025, the company's revenue composition shows that the exhibition industry accounts for 99.66%, while other businesses contribute 0.34% [1] - As of the report date, Miao Exhibition has a market capitalization of 4.4 billion yuan [1] Group 2 - Dapeng Industrial's strategic placement has resulted in significant profits for its controlling shareholder and family, with a subscription price of 9 yuan and a first-day listing price of 118 yuan, leading to a floating profit of 24.92 million yuan for the controlling shareholder and his brother [1]

Core Viewpoint - Miao Exhibition plans to apply for an initial public offering of H-shares and list on the Hong Kong Stock Exchange, focusing on the interests of existing shareholders and market conditions [1] Group 1: Company Overview - Miao Exhibition specializes in planning, organizing, promoting, and operating overseas exhibitions, primarily serving Chinese foreign trade enterprises and the exhibition industry [1] - The company has established a brand "Miao Lante," recognized in countries and regions involved in the Belt and Road Initiative, and operates two major brands, Homelife and Machinex, providing trade matching services for over 7,000 Chinese exhibitors annually [1][2] Group 2: International Expansion - Since 2025, Miao Exhibition has increased investment in global market expansion, establishing a wholly-owned subsidiary with an investment of 150 million yuan to focus on resource integration and business development [3] - The company has formed a joint venture with Panex WD International Limited to provide a one-stop solution for clients, including exhibition customer acquisition, overseas warehousing, local distribution, and supply chain finance [3] Group 3: Industry Trends - The Chinese exhibition industry is undergoing a deep transformation, with a slowdown in growth and structural optimization, as indicated by a survey showing a decline in companies participating in exhibitions in Germany and the U.S. [3] - Miao Exhibition has initiated an "export trade flash" action to help Chinese foreign trade enterprises reduce reliance on the U.S. market and quickly expand into non-U.S. markets [3] Group 4: Financial Performance - In the first three quarters of the year, Miao Exhibition reported revenue of 400 million yuan, a year-on-year decrease of 5.67%, and a net profit of 34.63 million yuan, down 49.17% year-on-year, impacted by canceled exhibitions and increased R&D investment in AI [4]

Group 1 - The core point of the article is that Miao Exhibition has announced the nomination of Mr. Lin Zhenpin as an independent director candidate for the company's sixth board of directors [2]